Literature DB >> 6191253

Nerve growth factor increases substance P, cholecystokinin and vasoactive intestinal polypeptide immunoreactivities in primary sensory neurones of newborn rats.

U Otten, H P Lorez.   

Abstract

Immunoreactive substance P, somatostatin, gastrin/cholecystokinin and vasoactive intestinal polypeptide were studied in lumbar dorsal root ganglia of 14-day-old rats treated from day 2 to 11 of life with nerve growth factor. Increased staining intensity of neuronal cell bodies and processes for substance P, gastrin/cholecystokinin and vasoactive intestinal polypeptide was observed by immunohistochemistry indicating increased neuronal peptide concentrations. These results were supported by radioimmunoassays showing increased ganglionic levels of substance P and vasoactive intestinal polypeptide. Both techniques, however, failed to show a significant increase of somatostatin levels.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6191253     DOI: 10.1016/0304-3940(82)90168-9

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

Review 1.  Vasoactive intestinal peptide.

Authors:  S I Said
Journal:  J Endocrinol Invest       Date:  1986-04       Impact factor: 4.256

2.  Differentiation of embryonic chick sympathetic neurons in vivo: ultrastructure, and quantitative determinations of catecholamines and somatostatin.

Authors:  S Ross; A Fischer; K Unsicker
Journal:  Cell Tissue Res       Date:  1990-04       Impact factor: 5.249

3.  Primary sensory neurons of the rat showing calcitonin gene-related peptide immunoreactivity and their relation to substance P-, somatostatin-, galanin-, vasoactive intestinal polypeptide- and cholecystokinin-immunoreactive ganglion cells.

Authors:  G Ju; T Hökfelt; E Brodin; J Fahrenkrug; J A Fischer; P Frey; R P Elde; J C Brown
Journal:  Cell Tissue Res       Date:  1987-02       Impact factor: 5.249

4.  Activin induces tactile allodynia and increases calcitonin gene-related peptide after peripheral inflammation.

Authors:  Pin Xu; Charles Van Slambrouck; Liliana Berti-Mattera; Alison K Hall
Journal:  J Neurosci       Date:  2005-10-05       Impact factor: 6.709

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.